On the recordMarch 29, 2023
The fees associated with this legislation is a collaborative investment between the FDA and America's animal health companies.
Source
congress.govThe fees associated with this legislation is a collaborative investment between the FDA and America's animal health companies.
Pence describes the funding model for the FDA and animal health companies.
Share
More from Greg Pence
Thank you, Chairwoman Rodgers and Ranking Member Pallone, for holding this hearing.
But the future of our transportation industry should not be a one-size-fits-all decision made by Washington.
I am proud to champion the fifth reauthorization of the Animal Drug User Fee Act with my colleague, Congresswoman Schrier.
Improving healthcare price transparency, however, would inject needed competition for healthcare facilities and ultimately lower costs for patients.